Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Vejle
Clinical trial register · Denmark

Clinical Trials in Vejle, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Vejle Hospital17 AstraZeneca14 Odense University Hospital9 Genmab8 Janssen Research & Development, LLC8
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Vejle

176 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
Pain Phenotype and Response to Corticosteroid Injection in Patients With Subacromial Pain Syndrome (SAPS)
NCT07792421Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain, Shoulder Pain, Shoulder Impingement Syndrome
Vejle Hospital
Observational
134
Vejle
2026-10-19
Not yet open
Nociplastic Pain in Patients Diagnosed With Subacromial Pain Syndrome (SAPS)
NCT07792434Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain, Shoulder Pain, Shoulder Impingement Syndrome
Vejle Hospital
Observational
400
Vejle
2026-10-19
Not yet open
Herlev Hospital
Phase 2
1,200
Aalborg, Aarhus, Herlev, Vejle
2026-10
Not yet open
University Hospital Schleswig-Holstein
Not applicable
30
Vejle
2026-09-28
Recruiting
CSL Behring
Phase 3
63
Vejle, Copenhagen, Roskilde
2026-09-15
Not yet open
Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging
NCT07799740Rectal Cancer, Total Mesorectal Excision, Laser Speckle Contrast Imaging, Indocyanine Green (ICG)
University of Aarhus
Not applicable
100
Herning, Vejle
2026-09-01
Recruiting
AstraZeneca
Phase 3
500
Aarhus N, Gandrup, Herlev, Holbæk, Hvidovre, Middelfart, Odense, Vejle
2026-08-24
Recruiting
AstraZeneca
Phase 3
600
Aarhus, Copenhagen, Gandrup, Herlev, Herning, Svendborg, Vejle, Viborg
2026-08-12
Recruiting
Eli Lilly and Company
Phase 2
606
Aalborg, Aarhus, Copenhagen, Hvidovre, Roskilde, Vejle
2026-08-07
Not yet open
University Hospital Schleswig-Holstein
Not applicable
32
Vejle
2026-07-01
Recruiting
Hoffmann-La Roche
Phase 3
380
Aarhus, København Ø, Vejle
2026-06-23
Recruiting
Risk-Based Lung Cancer Detection in COPD Patients
NCT07848815Lung Cancer (Diagnosis), COPD (Chronic Obstructive Pulmonary Disease)
Vejle Hospital
Not applicable
1,000
Vejle
2026-06-01
Recruiting
Vejle Hospital
Not applicable
1,000
Vejle
2026-05-26
Recruiting
University of Aarhus
Observational
175
Aalborg, Aarhus, Glostrup Municipality, Horsens, Silkeborg, Svendborg, Vejle
2026-05-06
Recruiting
Grifols Therapeutics LLC
Phase 3
40
Vejle
2026-05-05
Recruiting
Enlivex Therapeutics Ltd.
Phase 2
182
Gandrup, Herlev, Vejle
2026-05-01
Active, closed
Novo Nordisk A/S
Phase 3
606
Køge, Esbjerg, Vejle
2026-04-21
Recruiting
Incyte Corporation
Phase 3
588
Aalborg, Århus N, Herlev, Køge, Odense C, Vejle
2026-04-09
Not yet open
Odense University Hospital
Observational
920
Aalborg, Aarhus, Herlev, Vejle
2026-03-10
Recruiting
Enhanced COPD Management in Suspected Lung Cancer Patients
NCT07543601COPD (Chronic Obstructive Pulmonary Disease), Lung Cancer (Diagnosis), Lung Neoplasm Malignant, Lung Carcinoma
Ditte Krag-Hansen
Not applicable
280
Vejle
2026-03-06
Recruiting
Incyte Corporation
Phase 3
700
Aalborg, Odense C, Roskilde, Vejle
2026-03-05
Recruiting
Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)
NCT07460999Non-Small Cell Lung Cancer, Chronic Obstructive Lung Disease
Zealand University Hospital
Not applicable
100
Copenhagen, Næstved, Odense, Vejle
2026-03-01
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Vejle, Gandrup, Gistrup, Hellerup, Hillerød, Hvidovre
2026-02-24
Recruiting
Eli Lilly and Company
Phase 3
900
Gandrup, Herlev, Vejle
2026-02-09
Recruiting
AstraZeneca
Phase 3
1,100
Aalborg, Aarhus, Odense, Vejle
2025-12-29
Recruiting
Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions
NCT07343349Prostate Cancer Patients Undergoing External Radiation and Seed Implantation, High Risk Localised Prostate Carcinoma, Locally Advanced Prostate Cancer, Unfavourable Intermediate Risk Prostate Cancer
Copenhagen University Hospital, Rigshospitalet
Not applicable
1,016
Aarhus, Copenhagen, Vejle
2025-12-15
Recruiting
Pfizer
Phase 3
800
Odense C, Vejle, Aalborg, Copenhagen
2025-12-11
By invitation
Vejle Hospital
Observational
1,200
Odense, Vejle
2025-11-24
By invitation
The Feasibility of an Intervention Targeting Sources of Meaning in Cardiac Rehabilitation
NCT07262580Heart Disease, Mental Health Outcomes, Rehabilitation
University of Southern Denmark
Not applicable
80
Odense, Vejle
2025-11-20
Recruiting
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
NCT07201194Breast Cancer, Prostate Cancer, Lung Cancer, Gynaecologic Cancer
Vejle Hospital
Not applicable
90
Vejle
2025-11-17
Recruiting
Aarhus University Hospital
Observational
80
Aarhus, Herlev, Vejle
2025-11-13
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Copenhagen, Aalborg, Odense, Vejle
2025-10-23
Recruiting
Eli Lilly and Company
Phase 3
1,630
Copenhagen, Vejle
2025-10-22
Recruiting
Novartis Pharmaceuticals
Phase 1/2
188
Herlev, Odense C, Vejle
2025-10-15
Active, closed
Arctic Therapeutics
Phase 2
33
Gandrup, Herlev, Vejle
2025-10-14
Recruiting
Sanofi
Phase 4
218
Aalborg, Vejle
2025-09-22
Recruiting
Sanofi
Phase 3
942
Aalborg, Hvidovre, Næstved, Odense, Vejle
2025-09-16
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Esbjerg, Holbæk, Hvidovre, København S, Odense, Vejle
2025-09-06
Recruiting
AbbVie
Phase 2
140
Aarhus, Odense C, Vejle
2025-09-02
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Gandrup, Herlev, Vejle
2025-09-02
Not yet open
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Odense University Hospital
Phase 4
166
Aalborg, Esbjerg, Hvidovre, Nyborg, Odense, Vejle
2025-09-01
Recruiting
Prehabilitation to Patients With Prostate Cancer
NCT07162987Prostate Cancer (Diagnosis)
Odense University Hospital
Not applicable
20
Esbjerg, Nyborg, Vejle
2025-08-04
Not yet open
Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer
NCT06653751Prostate Cancer Patients Treated by Radiotherapy
University Hospital Schleswig-Holstein
Not applicable
28
Vejle
2025-07-01
Recruiting
Eli Lilly and Company
Phase 3
350
Aarhus, Copenhagen, Gistrup, Odense, Vejle
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Aarhus, Copenhagen, Gistrup, Odense, Vejle
2025-06-26
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Aalborg, Aarhus N, Hvidovre, København Ø, Vejle
2025-06-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Herlev, Aalborg, Odense, Vejle
2025-05-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Copenhagen, Herlev, Aalborg, Vejle
2025-04-09
Recruiting
Copenhagen University Hospital, Rigshospitalet
Phase 4
66
Copenhagen, Hillerød, Køge, Odense, Vejle, Gødstrup
2025-04-03
Recruiting
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949Metastatic Breast Cancer, Response Monitoring
Odense University Hospital
Not applicable
420
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Sønderborg, Vejle
2025-04-02
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 2
105
Sønderborg, Esbjerg, Vejle
2025-03-27
Recruiting
AstraZeneca
Phase 3
990
Aalborg, Hvidovre, Næstved, Odense C, Vejle
2025-03-25
Recruiting
Lars Wiuff Andersen
Not applicable
909
Aalborg, Aarhus N, Ballerup Municipality, Næstved, Vejle
2025-03-15
Recruiting
Vejle Hospital
Not applicable
30
Vejle
2025-03-01
Recruiting
Esbjerg Hospital - University Hospital of Southern Denmark
Not applicable
165
Esbjerg, Odense C, Svendborg, Vejle
2025-02-26
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-02-21
Not yet open
University Hospital Schleswig-Holstein
Not applicable
27
Vejle
2025-02-15
Recruiting
Thomas Lund
Phase 2
20
Odense, Vejle
2025-01-29
Recruiting
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
NCT06833749Osteoarthritis in the Knee, Obesity
KeyBioscience AG
Phase 2
600
Gandrup, Herlev, Vejle
2025-01-28
Recruiting
The ctDNA-RECIST Trial Part One
NCT06562348Gastrointestinal Neoplasm
Karen-Lise Garm Spindler
Phase 2
167
Aarhus, Vejle
2025-01-15
Recruiting
Janssen Research & Development, LLC
Phase 3
750
Aarhus N, Esbjerg, Frederiksberg, Herning, Svendborg, Vejle
2025-01-09
Recruiting
University Hospital Schleswig-Holstein
Not applicable
268
Vejle
2024-12-23
Active, closed
Amgen
Phase 3
707
Aarhus N, Vejle
2024-12-09
Recruiting
Vejle Hospital
Observational
1,000
Aabenraa, Vejle
2024-12-02
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Aalborg, Copenhagen, Vejle
2024-11-27
Active, closed
Vejle Hospital
Observational
20
Vejle
2024-11-15
Active, closed
Sanofi
Phase 2
556
Hvidovre, Vejle
2024-11-07
Active, closed
University Hospital Schleswig-Holstein
Not applicable
62
Vejle
2024-11-06
Recruiting
Pfizer
Phase 3
900
Odense, Vejle
2024-10-22
Recruiting
Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy
NCT06430814Chemotherapy-induced Peripheral Neuropathy
University of Southern Denmark
Observational
188
Odense, Sønderborg, Vejle
2024-10-10
Active, closed
AstraZeneca
Phase 3
310
Aalborg, Hvidovre, Svendborg, Vejle
2024-09-30
Recruiting
St. Olavs Hospital
Phase 4
3,000
Vejle
2024-09-18
Recruiting
Understanding and Tailored Treatment of Low Anterior Resection Syndrome
NCT07573371Low Anterior Resection Syndrome, Faecal Incontinence With Faecal Urgency, Faecal Incontinence, Colorectal (Colon or Rectal) Cancer Survivors
Aalborg University Hospital
Observational
145
Aalborg, Aarhus, Vejle
2024-09-17
By invitation
Odense University Hospital
Phase 2/3
80
Odense, Roskilde, Vejle
2024-09-09
Active, closed
Regeneron Pharmaceuticals
Phase 4
120
Vejle
2024-08-26
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Esbjerg, Gandrup, Vejle
2024-06-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Herlev, Aarhus N, Aalborg, Odense C, Sønderborg, Vejle
2024-06-24
Active, closed
Sanofi
Phase 2
185
Hellerup, Vejle
2024-06-20
Recruiting
North Estonia Medical Centre
Phase 2
50
Copenhagen, Odense, Vejle
2024-06-19
Recruiting
Curasight
Phase 2
168
Herlev, Vejle, Aalborg
2024-06-01
Active, closed
AbbVie
Phase 3
421
Odense, Vejle
2024-05-19
Active, closed
Eli Lilly and Company
Phase 3
10,000
Aabenraa, Aarhus, Gandrup, Herlev, Vejle
2024-04-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Copenhagen, Hillerød, Næstved, Odense C, Vejle
2024-04-14
Recruiting
Molecure S.A.
Phase 2
96
Vejle
2024-03-21
Active, closed
VIsualization of Coronary Artery Disease for Modification of RISK Factors
NCT06413641Coronary Artery Disease, Non-Obstructive Coronary Atherosclerosis
Aarhus University Hospital
Not applicable
273
Gødstrup, Aalborg, Aarhus, Esbjerg, Vejle
2024-03-12
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aabenraa, Aarhus, Copenhagen, Esbjerg, Gandrup, Herlev, Holbæk, Vejle
2024-03-05
Recruiting
AstraZeneca
Phase 3
5,250
Aalborg, Esbjerg, Hvidovre, København NV, Næstved, Vejle
2024-02-21
Active, closed
Genmab
Phase 3
1,095
Copenhagen Ø, Herning, Roskilde, Odense, Vejle
2024-02-05
Active, closed
Enlivex Therapeutics Ltd.
Phase 1/2
160
Gandrup, Herlev, Vejle
2024-01-26
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Aarhus, Odense C, Vejle
2024-01-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Copenhagen, Odense, Vejle
2023-12-31
Recruiting
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
NCT06685562Breast Cancer Patients, Melanoma Cancer, Prostate Cancer, Supportive Care in Cancer
Leiden University Medical Center
Observational
500
Vejle
2023-12-20
Recruiting
Janssen-Cilag Ltd.
Observational
900
Aalborg, Aarhus N, Copenhagen, Odense, Vejle
2023-12-18
Recruiting
Amgen
Phase 3
750
Aarhus N, Copenhagen, Herning, Sønderborg, Vejle
2023-11-16
Active, closed
Xentria, Inc.
Phase 1/2
32
Aalborg, Aarhus, Odense, Roskilde, Vejle
2023-11-10
Active, closed
Incyte Corporation
Phase 1
160
Roskilde, Vejle
2023-09-25
Active, closed
Boehringer Ingelheim
Phase 2
268
Aalborg, Hvidovre, København Ø, Odense, Roskilde, Vejle
2023-09-08
Recruiting
Danish Angle Closure Prevention Trial
NCT06077253Primary Angle Glaucoma Closure Suspect
University of Aarhus
Not applicable
242
Aalborg, Aarhus, Glostrup Municipality, Odense, Vejle
2023-09-01
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Aalborg, Hvidovre, Vejle
2023-08-30
Recruiting
University of Aarhus
Phase 3
1,204
Aarhus, Aalborg, Copenhagen, Herlev, Vejle
2023-08-25
Recruiting
Aarhus University Hospital
Not applicable
400
Herlev, Vejle, Aarhus
2023-08-02
Recruiting
Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
NCT05889247Non-small Cell Lung Cancer Metastatic
Zealand University Hospital
Not applicable
350
Hillerød, Næstved, Roskilde, Aalborg, Vejle
2023-07-28
Recruiting
Incyte Corporation
Phase 1
570
Copenhagen, Herlev, Odense C, Vejle
2023-07-24
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Aalborg, Hellerup, Hvidovre, Odense C, Roskilde, Vejle
2023-06-28
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Aalborg, Aarhus, Copenhagen, Herning, Odense C, Vejle
2023-03-29
Active, closed
Genentech, Inc.
Phase 1
90
Vejle
2023-03-21
Recruiting
AbbVie
Phase 1
210
Odense, Vejle
2023-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Aarhus, Aalborg, Odense C, Vejle
2023-03-16
Active, closed
Genmab
Phase 3
900
Copenhagen Ø, Aarhus, Roskilde, Odense, Vejle
2023-02-08
Recruiting
Odense University Hospital
Not applicable
300
Odense, Vejle, Roskilde, Copenhagen, Herlev
2023-02-01
Active, closed
Bristol-Myers Squibb
Phase 3
606
Aarhus, Roskilde, Odense, Vejle
2023-01-10
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Gandrup, Herlev, Vejle
2022-12-23
Active, closed
AstraZeneca
Phase 3
1,174
Copenhagen, Herning, Næstved, Odense, Sønderborg, Vejle
2022-11-28
Active, closed
University of Aarhus
Not applicable
84
Aarhus, Aarhus N, Copenhagen, Hellerup, Herning, Odense, Silkeborg, Vejle
2022-11-25
Recruiting
Copenhagen University Hospital, Rigshospitalet
Not applicable
138
Aalborg, Aarhus, Copenhagen, Herlev, Odense, Vejle
2022-11-01
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Aalborg, Herning, Roskilde, Vejle
2022-10-25
Active, closed
Genmab
Phase 3
549
Herning, Vejle
2022-09-20
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Aarhus, Copenhagen, Odense, Vejle
2022-09-08
Recruiting
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
NCT05444348Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Myeloid Leukemia
Christoffer Johansen
Not applicable
920
Aalborg, Aarhus, Esbjerg, Herning, Odense, Roskilde, Vejle
2022-08-01
Recruiting
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
NCT05404230Peripheral Neuropathy, Colorectal Cancer
Vejle Hospital
Not applicable
120
Aalborg, Aarhus, Sønderborg, Vejle
2022-07-15
Active, closed
Pfizer
Phase 2
108
Copenhagen, Aalborg, Vejle
2022-07-11
Recruiting
Zealand University Hospital
Not applicable
250
Aalborg, Herning, Odense, Roskilde, Sønderborg, Vejle
2022-03-01
Active, closed
Protons vs. Photons for High-risk Prostate Cancer
NCT05350475Prostate Cancer, Radiotherapy Side Effect
University of Aarhus
Not applicable
102
Copenhagen, Herlev, Aarhus, Aalborg, Næstved, Odense, Vejle
2022-03-01
Active, closed
Shared Decision Making on Radiation Dose for Lung Malignancies
NCT04940936Decision Making, Shared, Stereotactic Body Radiation Therapy, Lung Cancer, Non-small Cell, Radiation Toxicity
Vejle Hospital
Not applicable
40
Vejle
2021-11-12
Active, closed
AstraZeneca
Phase 3
454
Vejle
2021-10-28
Recruiting
Karen-Lise Garm Spindler
Phase 2
350
Aarhus N, Vejle
2021-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Aalborg, Aarhus N, Copenhagen, Odense, Vejle
2021-10-14
Active, closed
Bioventus LLC
Phase 2
210
Gandrup, Herlev, Vejle
2021-09-30
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Frederiksberg, Glostrup Municipality, Køge, Vejle
2021-08-30
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Copenhagen, Odense, Vejle
2021-06-24
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Vejle
2021-05-04
Active, closed
AstraZeneca
Phase 3
1,157
Copenhagen O, Sønderborg, Vejle
2021-04-26
Active, closed
Vejle Hospital
Observational
357
Vejle
2021-03-19
Active, closed
German CLL Study Group
Phase 3
897
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2021-03-01
Active, closed
Local Antibiotics for Breast Implants
NCT04731025Implant Complication, Implant Infection, Implant Site Infection, Implant Capsular Contracture
Mikkel Herly
Phase 3
1,003
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Roskilde, Vejle
2021-01-27
Active, closed
Genmab
Phase 3
483
Aalborg, Aarhus, Roskilde, Vejle
2021-01-13
Active, closed
Pfizer
Phase 3
841
Aalborg, Vejle, Copenhagen, Herlev, Odense C
2020-12-21
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Odense, Sønderborg, Vejle
2020-12-02
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Copenhagen, Aalborg, Aarhus, Odense, Roskilde, Vejle
2020-11-25
Active, closed
Genmab
Phase 1/2
543
Aarhus, Copenhagen, Odense, Vejle
2020-11-03
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Aalborg, Copenhagen, Herlev, Næstved, Odense, Vejle
2020-09-23
Recruiting
Ulrik Lassen
Phase 2
300
Aalborg, Aarhus, Copenhagen, Herlev, Odense, Roskilde, Vejle
2020-08-24
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2020-08-19
Active, closed
AstraZeneca
Phase 3
866
Aalborg, Copenhagen Ø, Odense, Vejle
2020-07-24
Active, closed
Vejle Hospital
Phase 2
83
Vejle
2020-06-26
Recruiting
The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
NCT04291378Early Breast Cancer, Radiation Associated Cardiac Failure
Danish Breast Cancer Cooperative Group
Not applicable
1,502
Aalborg, Aarhus, Copenhagen, Herlev, Næstved, Odense, Vejle
2020-06-01
Recruiting
Vejle Hospital
Not applicable
40
Vejle
2020-05-18
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Vejle
2020-01-29
Recruiting
Vejle Hospital
Phase 3
162
Aalborg, Copenhagen, Næstved, Roskilde, Vejle
2020-01-20
Recruiting
Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
NCT03730922Breast Neoplasm Female, Complication of Radiation Therapy, Breast Implant; Complications
Danish Breast Cancer Cooperative Group
Not applicable
590
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Roskilde, Vejle, Viborg
2020-01-01
Active, closed
Outcome After Revisions of Infected Knee Arthroplasties
NCT04427943Periprosthetic Knee Infection
Odense University Hospital
Observational
350
Aalborg, Copenhagen, Horsens, Næstved, Odense, Vejle
2020-01-01
Active, closed
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
NCT04335669Breast Cancer, Triple Negative Breast Neoplasms
Lund University Hospital
Phase 3
325
Vejle, Aalborg, Copenhagen, Esbjerg, Hillerød, Næstved, Sønderborg
2019-12-20
Active, closed
AstraZeneca
Phase 4
75
Aalborg, Aarhus N, Copenhagen, Hvidovre, Næstved, Odense C, Vejle
2019-10-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Odense C, Vejle, Herlev
2019-10-02
Active, closed
Celgene
Phase 1/2
424
Odense, Vejle
2019-09-30
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
DrugsGEN1042·Adrucil·Nab-paclitaxel·Pemetrexed
Genmab
Phase 1/2
350
Copenhagen, Herlev, Vejle
2019-09-17
Active, closed
Vejle Hospital
Not applicable
109
Aarhus, Næstved, Odense, Vejle
2019-09-02
Active, closed
Bristol-Myers Squibb
Phase 3
839
Herlev, Vejle
2019-08-05
Active, closed
Celgene
Phase 1/2
438
Aarhus, Copenhagen, Vejle
2019-05-20
Active, closed
Accelerated Treatment of Endocarditis
NCT03851575Infectious Endocarditis
Copenhagen University Hospital, Rigshospitalet
Not applicable
508
Copenhagen, Aarhus, Gødstrup, Hillerød, Hvidovre, Odense, Roskilde, Vejle
2019-01-17
Active, closed
AstraZeneca
Phase 2
367
Aalborg, Herlev, København Ø, Næstved, Odense, Vejle
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Aalborg, Aarhus N, Odense, Roskilde, Vejle
2019-01-04
Active, closed
AbbVie
Phase 3
265
Herlev, Aalborg, Odense, Vejle, Roskilde
2018-10-22
Recruiting
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
NCT03646955Local Neoplasm Recurrence, Distantly Metastatic Malignant Neoplasm, Death, Fibrosis Breast
Danish Breast Cancer Cooperative Group
Not applicable
926
Aalborg, Aarhus, Copenhagen, Herlev, Næstved, Odense, Vejle
2018-09-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Odense, Vejle
2018-08-21
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Copenhagen, Odense, Vejle
2018-06-26
Active, closed
AbbVie
Phase 2
156
Copenhagen Ø, Aarhus N, Odense, Vejle
2018-04-02
Active, closed
Odense University Hospital
Not applicable
97
Aalborg, Copenhagen, Horsens, Næstved, Odense, Vejle
2018-03-01
Active, closed
Danish Cardiovascular Screening Trial II
NCT03946410Cardiac Disease, Vascular Diseases
Odense University Hospital
Not applicable
38,000
Odense, Silkeborg, Svendborg, Vejle
2017-08-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Aalborg, Aarhus, Copenhagen, Herlev, Vejle
2016-12-22
Active, closed
Zimmer Biomet
Not applicable
332
Aalborg, Copenhagen, Næstved, Vejle
2016-12
Active, closed
Vejle Hospital
Observational
108
Aalborg, Copenhagen, Vejle
2015-09
Recruiting
Olfred Hansen
Not applicable
330
Aalborg, Aarhus, Copenhagen, Herlev, Næstved, Odense, Vejle
2015-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Copenhagen N, Arhus N, Copenhagen, Odense C, Vejle
2014-12-17
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Vejle
2014-04
Active, closed
Genentech, Inc.
Phase 2
378
Odense, Vejle
2008-10-16
Rows per page Showing 1–176 of 176
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/vejle

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 176 of those studies with a site in Vejle.

How many clinical trials are recruiting in Vejle?

86 of the 176 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 10 have not yet opened recruitment, 77 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Vejle), 176 studies
PhaseStudiesRecruitingShare
Phase 3713440.3%
Not applicable412523.3%
Phase 2251314.2%
Observational1578.5%
Phase 1/2915.1%
Phase 4734%
Phase 1422.3%
Phase 2/3412.3%

Most active sponsors

Lead sponsors with the most studies (Vejle)
Lead sponsorStudiesRecruiting
Vejle Hospital178
AstraZeneca146
Odense University Hospital93
Eli Lilly and Company86
Genmab80
Janssen Research & Development, LLC82
Merck Sharp & Dohme LLC76
University Hospital Schleswig-Holstein61
University of Aarhus63
AbbVie52
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.